Skip to main content

Table 1 Mouse serum toxicity profiles of LCL85 *

From: Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression

 

Treatment

Serum enzyme/protein level

 

LCL85 (mg/kg body weight)

 
 

Control (n = 2)

1 (n = 4)

5 (n = 3)

ALP (U/L)

65 ± 7.1

67.5 ± 11.6

66.7 ± 5.1

ALT (U/L)

20.5 ± 4.9

37.8 ± 10.2

57.3 ± 24.2

GGT (U/L)

<3.0

<3.0

<3.0

Albumin (g/dl)

3.2 ± 0.1

3.1 ± 0.1

3.2 ± 0.2

Glucose (mg/dl)

205 ± 29.7

198.5 ± 48.7

176.7 ± 23

Sodium (mmol/L)

150.5 ± 0.7

152.3 ± 2.2

151 ± 3

Potassium (mmol/L)

5.2 ± 0.1

6.4 ± 1

6.9 ± 0.5

Chloride (mmol/L)

108.5 ± 0.7

111 ± 2.6

111.7 ± 2.9

Bicarbonate (mmol/L)

16 ± 0

14.3 ± 2.2

15.7 ± 2.1

Anion Gap (mmol/L)

31 ± 0

33.5 ± 4.2

30.7 ± 2.5

Calcium ((mg/dl)

10.3 ± 0.1

10.2 ± 0.6

9.9 ± 0.3

Phosphorous (mg/dl)

8.8 ± 3.7

9.2 ± 1.9

8.5 ± 0.5

Cholesterol (mg/dl)

74.5 ± 9.2

68.8 ± 12.4

86 ± 4.6

UreaNitrogen (mg/dl)

24.5 ± 3.5

29.3 ± 4

26.3 ± 1.5

Total Bilirubin (mg/dl)

0.1 ± 0

0.1 ± 0

0.1 ± 0

Total Protein (g/dl)

4.5 ± 0.1

4.5 ± 0.3

4.8 ± 0.2

  1. *Measurements were performed 3 days after LCL85 injection.
  2. ALP, alkaline phosphatase; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase.